Target intelligence / Profile preview

Schistosome gut

Molecular classification
Other
01

Overview

The schistosome gut, or gastrodermis, is the primary digestive organ of Schistosoma parasites, responsible for the ingestion and breakdown of host erythrocytes (Caffrey et al., 2004). This blind-ending tube is lined with a syncytial epithelium that facilitates the absorption of nutrients derived from the proteolytic degradation of host hemoglobin (Sajid et al., 2003). Because the parasite is highly dependent on this process for growth and reproduction, the gut is a major site of interest for developing new anthelmintic therapies and vaccines. Key enzymes within the gut, such as cathepsin B1 and legumain, are often targeted to disrupt the parasite's metabolic pathways (Dalton et al., 2003). Furthermore, the gut releases diagnostic markers like Circulating Anodic Antigen (CAA) into the host's circulation, which are used to monitor infection intensity and treatment efficacy (Corstjens et al., 2014).

Other names
GastrodermisSchistosome digestive tractAlimentary canal
02

Mechanism of action

Anthelmintic agents may target the schistosome gut by inhibiting essential digestive enzymes like cathepsins or by causing structural damage to the gastrodermal lining, which prevents nutrient uptake and leads to parasite death (Cioli et al., 2014; Caffrey et al., 2004).

03

Biological functions

DigestionNutrient absorptionHemoglobin degradationExcretion of metabolic waste
04

Disease associations

SchistosomiasisInfection
05

Safety considerations

Host-parasite enzyme homology leading to off-target effectsDevelopment of drug resistanceLimited bioavailability to the gut lumen
06

Interacting drugs

Praziquantel

3 more in the full profile.

07

Biomarkers

Circulating Anodic Antigen (CAA)Circulating Cathodic Antigen (CCA)

Beyond the preview

Go deeper on Schistosome gut.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schistosome gut.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call